Download Docs
Export
Print

C

99707370 | Trademark citeCite Docket

Interested in this case?

To schedule a demo, contact us at sales@docketalarm.com. Track this case, and find millions of cases like it, let us show you how.
Filed March 17, 2026
Serial No. 99707370
Examining Attorney MATTHEW M DIGAN
Class human pharmaceuticals for the treatment of pulmonary diseases, pulmonary conditions, bronchoconstrictive diseases, bronchoconstrictive conditions, infectious diseases, neurological diseases and conditions, neuromuscular diseases and conditions, musculoskeletal disorders, and diseases and conditions associated with skeletal muscle dysfunction, skeletal muscle wasting, skeletal muscle atrophy, skeletal muscle weakness, metabolic diseases and disorders, diabetes, hypertension, vascular diseases, and diseases and conditions associated with dysfunction of non-muscle myosin; 005; 006; 018; 044; 046; 051; 052
C
Case Type Trademark
Status Notice of Allowance (NOA) sent (issued) to the applicant. Applicant must file a Statement of Use or Extension Request within six months of the NOA issuance date.
Last Updated: 4 days, 2 hours ago
Filing Date # Docket Text
to view the full docket.